Report Detail

Pharma & Healthcare Global Pregnancy Medication Market Growth 2022-2028

  • RnM4495269
  • |
  • 15 November, 2022
  • |
  • Global
  • |
  • 110 Pages
  • |
  • LPI(LP Information)
  • |
  • Pharma & Healthcare

The global market for Pregnancy Medication is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

The APAC Pregnancy Medication market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The United States Pregnancy Medication market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The Europe Pregnancy Medication market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The China Pregnancy Medication market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

Global key Pregnancy Medication players cover Glenmark Pharmaceuticals Ltd, Roche Holding AG, Pfizer, Alkem Laboratories Limited and Lupin Limited, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

Report Coverage
This latest report provides a deep insight into the global Pregnancy Medication market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.

This report aims to provide a comprehensive picture of the global Pregnancy Medication market, with both quantitative and qualitative data, to help readers understand how the Pregnancy Medication market scenario changed across the globe during the pandemic and Russia-Ukraine War.

The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.

Market Segmentation:
The study segments the Pregnancy Medication market and forecasts the market size by Type (Antianemia, Antacids and Antiallergic), by Application (Hospital Pharmacy, Retail Pharmacy and Online Pharmacy,), and region (APAC, Americas, Europe, and Middle East & Africa).

Segmentation by type
Antianemia
Antacids
Antiallergic
Analgesics
Antimicrobials
Laxatives
Vaccines
Nutritional Supplements
Others

Segmentation by application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Major companies covered
Glenmark Pharmaceuticals Ltd
Roche Holding AG
Pfizer
Alkem Laboratories Limited
Lupin Limited
Piramal Enterprises Limited
Amgen Inc
AbbVie
Janssen
Regeneron
Sanofi
Sun Pharma
Takeda
Viatris Inc(Mylan Inc.)
Dr. Reddy's Laboratories
Alembic Pharmaceuticals Ltd
Cipla Inc
GSK

Chapter Introduction
Chapter 1: Scope of Pregnancy Medication, Research Methodology, etc.
Chapter 2: Executive Summary, global Pregnancy Medication market size (sales and revenue) and CAGR, Pregnancy Medication market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Pregnancy Medication sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Pregnancy Medication sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Pregnancy Medication market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Glenmark Pharmaceuticals Ltd, Roche Holding AG, Pfizer, Alkem Laboratories Limited, Lupin Limited, Piramal Enterprises Limited, Amgen Inc, AbbVie and Janssen, etc.
Chapter 14: Research Findings and Conclusion


1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global Pregnancy Medication Annual Sales 2017-2028
    • 2.1.2 World Current & Future Analysis for Pregnancy Medication by Geographic Region, 2017, 2022 & 2028
    • 2.1.3 World Current & Future Analysis for Pregnancy Medication by Country/Region, 2017, 2022 & 2028
  • 2.2 Pregnancy Medication Segment by Type
    • 2.2.1 Antianemia
    • 2.2.2 Antacids
    • 2.2.3 Antiallergic
    • 2.2.4 Analgesics
    • 2.2.5 Antimicrobials
    • 2.2.6 Laxatives
    • 2.2.7 Vaccines
    • 2.2.8 Nutritional Supplements
    • 2.2.9 Others
  • 2.3 Pregnancy Medication Sales by Type
    • 2.3.1 Global Pregnancy Medication Sales Market Share by Type (2017-2022)
    • 2.3.2 Global Pregnancy Medication Revenue and Market Share by Type (2017-2022)
    • 2.3.3 Global Pregnancy Medication Sale Price by Type (2017-2022)
  • 2.4 Pregnancy Medication Segment by Application
    • 2.4.1 Hospital Pharmacy
    • 2.4.2 Retail Pharmacy
    • 2.4.3 Online Pharmacy
  • 2.5 Pregnancy Medication Sales by Application
    • 2.5.1 Global Pregnancy Medication Sale Market Share by Application (2017-2022)
    • 2.5.2 Global Pregnancy Medication Revenue and Market Share by Application (2017-2022)
    • 2.5.3 Global Pregnancy Medication Sale Price by Application (2017-2022)

3 Global Pregnancy Medication by Company

  • 3.1 Global Pregnancy Medication Breakdown Data by Company
    • 3.1.1 Global Pregnancy Medication Annual Sales by Company (2020-2022)
    • 3.1.2 Global Pregnancy Medication Sales Market Share by Company (2020-2022)
  • 3.2 Global Pregnancy Medication Annual Revenue by Company (2020-2022)
    • 3.2.1 Global Pregnancy Medication Revenue by Company (2020-2022)
    • 3.2.2 Global Pregnancy Medication Revenue Market Share by Company (2020-2022)
  • 3.3 Global Pregnancy Medication Sale Price by Company
  • 3.4 Key Manufacturers Pregnancy Medication Producing Area Distribution, Sales Area, Product Type
    • 3.4.1 Key Manufacturers Pregnancy Medication Product Location Distribution
    • 3.4.2 Players Pregnancy Medication Products Offered
  • 3.5 Market Concentration Rate Analysis
    • 3.5.1 Competition Landscape Analysis
    • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
  • 3.6 New Products and Potential Entrants
  • 3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Pregnancy Medication by Geographic Region

  • 4.1 World Historic Pregnancy Medication Market Size by Geographic Region (2017-2022)
    • 4.1.1 Global Pregnancy Medication Annual Sales by Geographic Region (2017-2022)
    • 4.1.2 Global Pregnancy Medication Annual Revenue by Geographic Region
  • 4.2 World Historic Pregnancy Medication Market Size by Country/Region (2017-2022)
    • 4.2.1 Global Pregnancy Medication Annual Sales by Country/Region (2017-2022)
    • 4.2.2 Global Pregnancy Medication Annual Revenue by Country/Region
  • 4.3 Americas Pregnancy Medication Sales Growth
  • 4.4 APAC Pregnancy Medication Sales Growth
  • 4.5 Europe Pregnancy Medication Sales Growth
  • 4.6 Middle East & Africa Pregnancy Medication Sales Growth

5 Americas

  • 5.1 Americas Pregnancy Medication Sales by Country
    • 5.1.1 Americas Pregnancy Medication Sales by Country (2017-2022)
    • 5.1.2 Americas Pregnancy Medication Revenue by Country (2017-2022)
  • 5.2 Americas Pregnancy Medication Sales by Type
  • 5.3 Americas Pregnancy Medication Sales by Application
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC Pregnancy Medication Sales by Region
    • 6.1.1 APAC Pregnancy Medication Sales by Region (2017-2022)
    • 6.1.2 APAC Pregnancy Medication Revenue by Region (2017-2022)
  • 6.2 APAC Pregnancy Medication Sales by Type
  • 6.3 APAC Pregnancy Medication Sales by Application
  • 6.4 China
  • 6.5 Japan
  • 6.6 South Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia
  • 6.10 China Taiwan

7 Europe

  • 7.1 Europe Pregnancy Medication by Country
    • 7.1.1 Europe Pregnancy Medication Sales by Country (2017-2022)
    • 7.1.2 Europe Pregnancy Medication Revenue by Country (2017-2022)
  • 7.2 Europe Pregnancy Medication Sales by Type
  • 7.3 Europe Pregnancy Medication Sales by Application
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa Pregnancy Medication by Country
    • 8.1.1 Middle East & Africa Pregnancy Medication Sales by Country (2017-2022)
    • 8.1.2 Middle East & Africa Pregnancy Medication Revenue by Country (2017-2022)
  • 8.2 Middle East & Africa Pregnancy Medication Sales by Type
  • 8.3 Middle East & Africa Pregnancy Medication Sales by Application
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

  • 10.1 Raw Material and Suppliers
  • 10.2 Manufacturing Cost Structure Analysis of Pregnancy Medication
  • 10.3 Manufacturing Process Analysis of Pregnancy Medication
  • 10.4 Industry Chain Structure of Pregnancy Medication

11 Marketing, Distributors and Customer

  • 11.1 Sales Channel
    • 11.1.1 Direct Channels
    • 11.1.2 Indirect Channels
  • 11.2 Pregnancy Medication Distributors
  • 11.3 Pregnancy Medication Customer

12 World Forecast Review for Pregnancy Medication by Geographic Region

  • 12.1 Global Pregnancy Medication Market Size Forecast by Region
    • 12.1.1 Global Pregnancy Medication Forecast by Region (2023-2028)
    • 12.1.2 Global Pregnancy Medication Annual Revenue Forecast by Region (2023-2028)
  • 12.2 Americas Forecast by Country
  • 12.3 APAC Forecast by Region
  • 12.4 Europe Forecast by Country
  • 12.5 Middle East & Africa Forecast by Country
  • 12.6 Global Pregnancy Medication Forecast by Type
  • 12.7 Global Pregnancy Medication Forecast by Application

13 Key Players Analysis

  • 13.1 Glenmark Pharmaceuticals Ltd
    • 13.1.1 Glenmark Pharmaceuticals Ltd Company Information
    • 13.1.2 Glenmark Pharmaceuticals Ltd Pregnancy Medication Product Offered
    • 13.1.3 Glenmark Pharmaceuticals Ltd Pregnancy Medication Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.1.4 Glenmark Pharmaceuticals Ltd Main Business Overview
    • 13.1.5 Glenmark Pharmaceuticals Ltd Latest Developments
  • 13.2 Roche Holding AG
    • 13.2.1 Roche Holding AG Company Information
    • 13.2.2 Roche Holding AG Pregnancy Medication Product Offered
    • 13.2.3 Roche Holding AG Pregnancy Medication Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.2.4 Roche Holding AG Main Business Overview
    • 13.2.5 Roche Holding AG Latest Developments
  • 13.3 Pfizer
    • 13.3.1 Pfizer Company Information
    • 13.3.2 Pfizer Pregnancy Medication Product Offered
    • 13.3.3 Pfizer Pregnancy Medication Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.3.4 Pfizer Main Business Overview
    • 13.3.5 Pfizer Latest Developments
  • 13.4 Alkem Laboratories Limited
    • 13.4.1 Alkem Laboratories Limited Company Information
    • 13.4.2 Alkem Laboratories Limited Pregnancy Medication Product Offered
    • 13.4.3 Alkem Laboratories Limited Pregnancy Medication Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.4.4 Alkem Laboratories Limited Main Business Overview
    • 13.4.5 Alkem Laboratories Limited Latest Developments
  • 13.5 Lupin Limited
    • 13.5.1 Lupin Limited Company Information
    • 13.5.2 Lupin Limited Pregnancy Medication Product Offered
    • 13.5.3 Lupin Limited Pregnancy Medication Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.5.4 Lupin Limited Main Business Overview
    • 13.5.5 Lupin Limited Latest Developments
  • 13.6 Piramal Enterprises Limited
    • 13.6.1 Piramal Enterprises Limited Company Information
    • 13.6.2 Piramal Enterprises Limited Pregnancy Medication Product Offered
    • 13.6.3 Piramal Enterprises Limited Pregnancy Medication Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.6.4 Piramal Enterprises Limited Main Business Overview
    • 13.6.5 Piramal Enterprises Limited Latest Developments
  • 13.7 Amgen Inc
    • 13.7.1 Amgen Inc Company Information
    • 13.7.2 Amgen Inc Pregnancy Medication Product Offered
    • 13.7.3 Amgen Inc Pregnancy Medication Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.7.4 Amgen Inc Main Business Overview
    • 13.7.5 Amgen Inc Latest Developments
  • 13.8 AbbVie
    • 13.8.1 AbbVie Company Information
    • 13.8.2 AbbVie Pregnancy Medication Product Offered
    • 13.8.3 AbbVie Pregnancy Medication Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.8.4 AbbVie Main Business Overview
    • 13.8.5 AbbVie Latest Developments
  • 13.9 Janssen
    • 13.9.1 Janssen Company Information
    • 13.9.2 Janssen Pregnancy Medication Product Offered
    • 13.9.3 Janssen Pregnancy Medication Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.9.4 Janssen Main Business Overview
    • 13.9.5 Janssen Latest Developments
  • 13.10 Regeneron
    • 13.10.1 Regeneron Company Information
    • 13.10.2 Regeneron Pregnancy Medication Product Offered
    • 13.10.3 Regeneron Pregnancy Medication Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.10.4 Regeneron Main Business Overview
    • 13.10.5 Regeneron Latest Developments
  • 13.11 Sanofi
    • 13.11.1 Sanofi Company Information
    • 13.11.2 Sanofi Pregnancy Medication Product Offered
    • 13.11.3 Sanofi Pregnancy Medication Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.11.4 Sanofi Main Business Overview
    • 13.11.5 Sanofi Latest Developments
  • 13.12 Sun Pharma
    • 13.12.1 Sun Pharma Company Information
    • 13.12.2 Sun Pharma Pregnancy Medication Product Offered
    • 13.12.3 Sun Pharma Pregnancy Medication Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.12.4 Sun Pharma Main Business Overview
    • 13.12.5 Sun Pharma Latest Developments
  • 13.13 Takeda
    • 13.13.1 Takeda Company Information
    • 13.13.2 Takeda Pregnancy Medication Product Offered
    • 13.13.3 Takeda Pregnancy Medication Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.13.4 Takeda Main Business Overview
    • 13.13.5 Takeda Latest Developments
  • 13.14 Viatris Inc(Mylan Inc.)
    • 13.14.1 Viatris Inc(Mylan Inc.) Company Information
    • 13.14.2 Viatris Inc(Mylan Inc.) Pregnancy Medication Product Offered
    • 13.14.3 Viatris Inc(Mylan Inc.) Pregnancy Medication Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.14.4 Viatris Inc(Mylan Inc.) Main Business Overview
    • 13.14.5 Viatris Inc(Mylan Inc.) Latest Developments
  • 13.15 Dr. Reddy's Laboratories
    • 13.15.1 Dr. Reddy's Laboratories Company Information
    • 13.15.2 Dr. Reddy's Laboratories Pregnancy Medication Product Offered
    • 13.15.3 Dr. Reddy's Laboratories Pregnancy Medication Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.15.4 Dr. Reddy's Laboratories Main Business Overview
    • 13.15.5 Dr. Reddy's Laboratories Latest Developments
  • 13.16 Alembic Pharmaceuticals Ltd
    • 13.16.1 Alembic Pharmaceuticals Ltd Company Information
    • 13.16.2 Alembic Pharmaceuticals Ltd Pregnancy Medication Product Offered
    • 13.16.3 Alembic Pharmaceuticals Ltd Pregnancy Medication Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.16.4 Alembic Pharmaceuticals Ltd Main Business Overview
    • 13.16.5 Alembic Pharmaceuticals Ltd Latest Developments
  • 13.17 Cipla Inc
    • 13.17.1 Cipla Inc Company Information
    • 13.17.2 Cipla Inc Pregnancy Medication Product Offered
    • 13.17.3 Cipla Inc Pregnancy Medication Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.17.4 Cipla Inc Main Business Overview
    • 13.17.5 Cipla Inc Latest Developments
  • 13.18 GSK
    • 13.18.1 GSK Company Information
    • 13.18.2 GSK Pregnancy Medication Product Offered
    • 13.18.3 GSK Pregnancy Medication Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.18.4 GSK Main Business Overview
    • 13.18.5 GSK Latest Developments

14 Research Findings and Conclusion

Summary:
Get latest Market Research Reports on Pregnancy Medication. Industry analysis & Market Report on Pregnancy Medication is a syndicated market report, published as Global Pregnancy Medication Market Growth 2022-2028. It is complete Research Study and Industry Analysis of Pregnancy Medication market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

Last updated on

REPORT YOU MIGHT BE INTERESTED

Purchase this Report

$3,660.00
$7,320.00
2,986.56
5,973.12
3,477.00
6,954.00
492,709.20
985,418.40
297,850.80
595,701.60
Credit card Logo

Related Reports


Reason to Buy

Request for Sample of this report